Observations placeholder
Orap
Identifier
019814
Type of Spiritual Experience
Background
A description of the experience
Pimozide (Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the QT interval.
Medical uses
Pimozide is used in its oral preparation in schizophrenia and chronic psychosis (on-label indications in Europe only), Tourette syndrome and resistant tics (Europe, USA and Canada).
Pimozide has been used in the treatment of delusional disorder and paranoid personality disorder It has also been used for delusions of parasitosis
Use as a Listeria monocytogenes inhibitor has been described.
Side effects
Very common (>10% frequency) side effects include
- Akinesia
- Dizziness
- Somnolence
- Hyperhidrosis
- Nocturia
- Speech disorder
- Dry mouth
- Constipation
On Dec, 28, 2016 385 people reported to have side effects when taking Orap.
Among them, 5 people (1.3%) have Hallucination
On Jan, 17, 2016: 330 people reported to have side effects when taking Orap. Among them, 10 people (3.03%) have Death.
Time on Orap when people have Death :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Death | 0.00% | 0.00% | 0.00% | 50.00% | 0.00% | 0.00% | 50.00% |
Gender of people who have Death when taking Orap :
| Female | Male | |
| Death | 50.00% | 50.00% |
Age of people who have Death when taking Orap :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Death | 0.00% | 0.00% | 25.00% | 25.00% | 0.00% | 0.00% | 25.00% | 25.00% |
Top conditions involved for these people :
- Schizophrenia (4 people, 40.00%)
- Bipolar disorder (2 people, 20.00%)
- Tic (1 people, 10.00%)